Biopharmaceutical company TNF Pharmaceuticals Inc (Nasdaq: TNFA) announced on Wednesday that it presented its oral TNF-alpha inhibit...
Evommune initiates EVO756 Phase 2b trial in adults with chronic spontaneous urticaria
Sanofi advances respiratory pipeline with positive amlitelimab data and expanded clinical programmes
Halozyme Therapeutics' VYVGART Hytrulo prefilled syringe for self-injection receives US FDA approval
Alphyn doses first patient in Phase 2b trial of Zabalafin Hydrogel in Australia
Ananda Pharma's MRX1 receives ethics approval for Phase 1 study in Australia
Organon acquires US rights to TOFIDENCE from Biogen
Dupixent receives approval in Japan as first biologic for COPD treatment
Celltrion adds STEQEYMA to Costco Member Prescription Program
Alys Pharmaceuticals doses first patient in Phase IIa trial of ALY-101
Bio-Thera Solutions signs commercialisation and licence agreements with Dr. Reddy's Laboratories
Spyre Therapeutics starts dosing in Phase 1 clinical trial of SPY003
Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA
Journey Medical launches Emrosi for treatment of rosacea
Evommune enrols first patient in EVO301 Phase 2 trial
Revelation Biosciences reports Gemini's anti-inflammatory potential in PBMC study